Literature DB >> 34820115

A computational model of contributors to pulmonary hypertensive disease: impacts of whole lung and focal disease distributions.

Behdad Shaarbaf Ebrahimi1, Merryn H Tawhai1, Haribalan Kumar1, Kelly S Burrowes1, Eric A Hoffman2, Margaret L Wilsher3,4, David Milne5, Alys R Clark1.   

Abstract

Pulmonary hypertension has multiple etiologies and so can be difficult to diagnose, prognose, and treat. Diagnosis is typically made via invasive hemodynamic measurements in the main pulmonary artery and is based on observed elevation of mean pulmonary artery pressure. This static mean pressure enables diagnosis, but does not easily allow assessment of the severity of pulmonary hypertension, nor the etiology of the disease, which may impact treatment. Assessment of the dynamic properties of pressure and flow data obtained from catheterization potentially allows more meaningful assessment of the strain on the right heart and may help to distinguish between disease phenotypes. However, mechanistic understanding of how the distribution of disease in the lung leading to pulmonary hypertension impacts the dynamics of blood flow in the main pulmonary artery and/or the pulmonary capillaries is lacking. We present a computational model of the pulmonary vasculature, parameterized to characteristic features of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension to help understand how the two conditions differ in terms of pulmonary vascular response to disease. Our model incorporates key features known to contribute to pulmonary vascular function in health and disease, including anatomical structure and multiple contributions from gravity. The model suggests that dynamic measurements obtained from catheterization potentially distinguish between distal and proximal vasculopathy typical of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. However, the model suggests a non-linear relationship between these data and vascular structural changes typical of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension which may impede analysis of these metrics to distinguish between cohorts.
© The Author(s) 2021.

Entities:  

Keywords:  computational modeling; pulmonary circulation; pulmonary hypertension; vascular remodeling

Year:  2021        PMID: 34820115      PMCID: PMC8607494          DOI: 10.1177/20458940211056527

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   2.886


  71 in total

1.  The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects.

Authors:  D HEATH; J E EDWARDS
Journal:  Circulation       Date:  1958-10       Impact factor: 29.690

2.  Fractal modeling of pulmonary blood flow heterogeneity.

Authors:  R W Glenny; H T Robertson
Journal:  J Appl Physiol (1985)       Date:  1991-03

Review 3.  Development and pathology of pulmonary hypertension.

Authors:  Rubin M Tuder; Steven H Abman; Thomas Braun; Frédérique Capron; Troy Stevens; Patricia A Thistlethwaite; Sheila G Haworth
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

Review 4.  Controversies, uncertainties and future research on the treatment of chronic thromboembolic pulmonary hypertension.

Authors:  Andrew Peacock; Gérald Simonneau; Lewis Rubin
Journal:  Proc Am Thorac Soc       Date:  2006-09

5.  On coupling a lumped parameter heart model and a three-dimensional finite element aorta model.

Authors:  H J Kim; I E Vignon-Clementel; C A Figueroa; J F LaDisa; K E Jansen; J A Feinstein; C A Taylor
Journal:  Ann Biomed Eng       Date:  2009-07-17       Impact factor: 3.934

6.  Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension.

Authors:  K M Moser; C M Bloor
Journal:  Chest       Date:  1993-03       Impact factor: 9.410

7.  Input impedance of the pulmonary arterial system in normal man. Effects of respiration and comparison to systemic impedance.

Authors:  J P Murgo; N Westerhof
Journal:  Circ Res       Date:  1984-06       Impact factor: 17.367

8.  Pulmonary vascular input impedance is a combined measure of pulmonary vascular resistance and stiffness and predicts clinical outcomes better than pulmonary vascular resistance alone in pediatric patients with pulmonary hypertension.

Authors:  Kendall S Hunter; Po-Feng Lee; Craig J Lanning; D Dunbar Ivy; K Scott Kirby; Lori R Claussen; K Chen Chan; Robin Shandas
Journal:  Am Heart J       Date:  2007-09-27       Impact factor: 4.749

9.  A multiscale model of vascular function in chronic thromboembolic pulmonary hypertension.

Authors:  Mitchel J Colebank; M Umar Qureshi; Sudarshan Rajagopal; Richard A Krasuski; Mette S Olufsen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-06-18       Impact factor: 5.125

10.  Lung and fissure shape is associated with age in healthy never-smoking adults aged 20-90 years.

Authors:  Mahyar Osanlouy; Alys R Clark; Haribalan Kumar; Clair King; Margaret L Wilsher; David G Milne; Ken Whyte; Eric A Hoffman; Merryn H Tawhai
Journal:  Sci Rep       Date:  2020-09-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.